A point-monitoring fluorescence diagnostic system based on a low-energy pulsed laser, fiber transmission optics and an optical multichannel analyzer was used for diagnosis of patients with bladder malignancies. 24 patients with bladder carcinoma, carcinoma in situ and/or dysplasia were injected with 0.35 or 0.5 mg/kg body weight with Photofrin 48 hours prior to the investigation. The ratio between the red sensitizer emission and the bluish tissue autofluorescence proved to provide excellent demarcation between papillary tumours and normal bladder wall. Certain cases of dysplasia could also be differentiated from normal mucosa. Benign exofytic lesion such as malakoplakia appeared different from malignant tumours in fluorescence. Flat suspicious bladder mucosa such as seen in infectious diseases or after radiation therapy appeared normal in terms of fluorescence.
INTRODUCTION
Laser-induced fluoscence (LIF) is a relatively novel but attractive tool in tumour diagnostics. ' In connection with fibre optics it hits shown to be useful for loa,Jizing malignant tumours in the bronchial tree, and in the urinary bladder among several locations. LIF is of particular value in the diagnosis of early tumours, such as occult cancer not visible to the eye nor detectable with standard diagnostic methods. In order to obtain a significant fluorescence demarcation between malignant tumour and surrounding tissue, a fluorescent drug is injected about 48 hours prior to1 12the investigation. A clinically used drug is Hematoporphyrin Derivative (HpD) -or its purified form Photofrin with a characteristic dual-peaked fluorescence structure in the red wavelength region. As O-8194-0653-8/91/$4.OO the drug is retained in malignant tissue the fluorescence is characterized by the red dual peaked fluorescence in the tumour areas, which is not seen in normal
tissue. An unwanted side-effect when using HpD is a skin photosensitization during a period of about 4-6 weeks after injection. As the skin effect is dose dependent the problem can be avoided by using low dose injection in conjunction with sensitive diagnostic equipment. During the last years a large variety of other fluorescent drugs have been developed such as phalocyanines, chiorin and benzoporphyrin (BPD). One of the most promising is BPD which does not give rise to a prolonged skin sensitization although with good tumour sensitizing properties. The intrinsic fluorescence from the tissue, the autofluorescence, can also be incorporated in the fluorescence characterization of biological tissue. It has been 1hown to decrease in malignant tumours compared to normal tissue for UV excitation.
In the demarcation of malignant tumours it is advantageous to use both the HpD related fluorescence and the autofluorescence to enhance the tumour demarcation. The drug specific fluorescence and the autofluorescence can also be used to form a ratio which has the advantage of being dimensionless. Such a ratio will be independent of the distance to and the topography of the object and also to laser intensity variations, parameters that might be difficult to control in clinical use. Furthermore, in many cases the shape of the autofluorescence might contain information that14n be used to increase the demarcation between tumour and surrounding tissue.
This has been observed for many different tumour types using a nitrogen laser (337 nm) as an excitation source.
In this paper we report on an investigation of various types of bladder malignancies in 24 patients injected with 0.35 or 0.50 mg/kg b.w. of Photofrin.
Bladder carcinoma and carcinoma in situ were easily demarcated from normal mucosa not only on the basis of the porphyrin fluorescence but also due to the different autofluorescence in the blue spectral region. Fluorescence spectra were also recorded from several cases of areas with dysplasia. The spectral shape was different for different grades of dysplastic transformation.
MATERIAL AND METHODS
2.1. Fluorescence recordings. As an excitation source a nitrogen laser (Laser Science VSL 337) was used alone or in conjunction with a dye laser, producing 3 ns pulses at 337 nm and 405 nm, respectively. The laser light was directed into a 600 im fluorescence free quartz fibre, which was placed in contact with the object. The fluorescence light was collected by the same fibre and directed into an optical multichannel analyzer (EG&G PARC OMA III model 1460) equipped with an image-intensified 1024 element diode array detector. The overall spectral resolution of the system was about 10 nm. The system is described in detail in 
RESULTS AND DISCUSSION
The evaluated data from a scan across three flat malignant bladder tumours with In Fig. 2 fluorescence emission spectra from normal bladder mucosa and a superficial malignant tumour are shown for excitation at wavelengths 405 nm and 337 nm in a patient injected with 0.35 mg/kg b.w. Photofrin 48 hours prior to the investigation. As can be seen in the figure the tumour area is recognized by a very low autofluorescence intensity in the blue-green wavelength region for both excitation wavelengths. The drug specific signal at about 630 nm can be identified for both excitation wavelengths although better at 405 nm, which is close to the prominent absorption peak for porphyrin at about 400 nm. The spectra excited at 337 rim show another difference in the autofluorescence with the maximum intensities occurring at wavelengths separated by 80 nm.
The prominent fluorescence contribution at about 390 nm for the normal mucosa is not present for the malignant tumour.
In Fig. 3 we give some examples of the fluorescence signature of two different stages of dysplastic transformation, mild and severe dysplasia in the bladder wall together with the signature of normal mucosa. The autofluorescence peaking at about 480 nm shows a decreasing intensity in the regions of dysplasia. Beside the difference in the autofluorescence there is also a sign of porphyrin in the spectra from the dysplastic regions, which is not seen in the spectrum from the normal mucosa. It is interesting to note the successive transformation of the fluorescence spectra when going from normal mucosa to severe dysplasia, which are similar to the spectra obtained from carcinoma in situ. A known chromophore fluorescing at about 470 nm is NADH. It has been suggested by us and others that the deced autofluorescence in malignant tissue might be due to less content of 
